{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:30:49Z","timestamp":1778549449452,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fatty acids have diverse immunomodulatory functions and the potential to be associated with inflammatory responses in sarcoidosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The serum levels of multiple long-chain fatty acids (LCFAs) were compared between 63 patients with sarcoidosis and 38 healthy controls. The associations of LCFAs with clinical outcomes of sarcoidosis were also evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The patients with sarcoidosis had significantly lower levels of n-3 poly-unsaturated fatty acids (PUFAs) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and n-6 PUFAs (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) than the healthy controls. However, there were no significant differences in the levels of saturated fatty acids (SFAs) and mono-unsaturated fatty acids (MUFAs) between the two groups. On multivariate logistic analysis, lower levels of n-3 PUFAs, n-6 PUFAs, and n-3\/n-6 ratio were predictive of sarcoidosis. Among the patients with sarcoidosis, those with multiple organ involvement had significantly lower levels of n-3 PUFAs and n-3\/n-6 ratio than those with single organ involvement. There were no significant differences in the levels of n-6 PUFAs, SFAs, and MUFAs between the patients with multiple and single organ involvement. On multivariate logistic analysis, lower levels of SFAs and n-3\/n-6 ratio were predictive of multiple organ involvement. The levels of LCFAs had no significant association with radiographic stage or spontaneous remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Assessment of LCFA profiles may be useful for the diagnosis of sarcoidosis and evaluation of the disease activity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02084-x","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T14:06:26Z","timestamp":1659017186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Takahito","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2084_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ER. Am J Respir Crit Care Med. 1999;160:736\u201355. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10670511.","journal-title":"Am J Respir Crit Care Med"},{"key":"2084_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","volume":"76","author":"M Thillai","year":"2021","unstructured":"Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho LP, Kouranos V, et al. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021;76:4\u201320.","journal-title":"Thorax"},{"key":"2084_CR3","first-page":"1","volume":"12 November","author":"H Zhang","year":"2021","unstructured":"Zhang H, Costabel U, Dai H. The Role of Diverse Immune Cells in Sarcoidosis. Front Immunol. 2021;12 November:1\u201310.","journal-title":"Front Immunol"},{"key":"2084_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","volume":"38","author":"L Erika","year":"2013","unstructured":"Erika L. Pearce, Edward J. Pearce. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633\u201343.","journal-title":"Immunity"},{"key":"2084_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nri1710","volume":"5","author":"CJ Fox","year":"2005","unstructured":"Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: Energy metabolism and the T-cell response. Nat Rev Immunol. 2005;5:844\u201352.","journal-title":"Nat Rev Immunol"},{"key":"2084_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","volume":"26","author":"RJ Kishton","year":"2017","unstructured":"Kishton RJ, Sukumar M, Restifo NP. Metabolic regulation of T cell longevity and function in tumor immunotherapy. Cell Metab. 2017;26:94\u2013109.","journal-title":"Cell Metab"},{"key":"2084_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","volume":"19","author":"KL O\u2019Brien","year":"2019","unstructured":"O\u2019Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019;19:282\u201390.","journal-title":"Nat Rev Immunol"},{"key":"2084_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3466","volume":"17","author":"R Newton","year":"2016","unstructured":"Newton R, Priyadharshini B, Turka LA. Immunometabolism of regulatory T cells. Nat Immunol. 2016;17:618\u201325.","journal-title":"Nat Immunol"},{"key":"2084_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","volume":"36","author":"M Lochner","year":"2015","unstructured":"Lochner M, Berod L, Sparwasser T. Fatty acid metabolism in the regulation of T cell function. Trends Immunol. 2015;36:81\u201391.","journal-title":"Trends Immunol"},{"key":"2084_CR10","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20205028"},{"key":"2084_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/intimm\/dxy086","volume":"31","author":"T Nagatake","year":"2019","unstructured":"Nagatake T, Kunisawa J. Emerging roles of metabolites of \u03c93 and \u03c96 essential fatty acids in the control of intestinal inflammation. Int Immunol. 2019;31:569\u201377.","journal-title":"Int Immunol"},{"key":"2084_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","volume":"43","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, J\u00f6rg S, Duscha A, Berg J, Manzel A, Waschbisch A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43:817\u201329.","journal-title":"Immunity"},{"key":"2084_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0954-y","volume":"14","author":"A Hammer","year":"2017","unstructured":"Hammer A, Schliep A, J\u00f6rg S, Haghikia A, Gold R, Kleinewietfeld M, et al. Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation. J Neuroinflammation. 2017;14:1\u20139.","journal-title":"J Neuroinflammation"},{"key":"2084_CR14","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.4049\/jimmunol.174.9.5390","volume":"174","author":"AR Weatherill","year":"2005","unstructured":"Weatherill AR, Lee JY, Zhao L, Lemay DG, Youn HS, Hwang DH. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol. 2005;174:5390\u20137.","journal-title":"J Immunol"},{"key":"2084_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbalip.2018.11.012","volume":"1864","author":"AM van der Does","year":"2019","unstructured":"van der Does AM, Heijink M, Mayboroda OA, Persson LJ, Aanerud M, Bakke P, et al. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls. Biochim Biophys Acta - Mol Cell Biol Lipids. 2019;1864:224\u201333. doi:https:\/\/doi.org\/10.1016\/j.bbalip.2018.11.012.","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"2084_CR16","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1165\/rcmb.2018-0324OC","volume":"61","author":"SG Chu","year":"2019","unstructured":"Chu SG, Villalba JA, Liang X, Xiong K, Tsoyi K, Ith B, et al. Palmitic acid-rich high-fat diet exacerbates experimental pulmonary fibrosis by modulating endoplasmic reticulum stress. Am J Respir Cell Mol Biol. 2019;61:737\u201346.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2084_CR17","doi-asserted-by":"crossref","unstructured":"Scaioli E, Liverani E, Belluzzi A. The imbalance between N-6\/N-3 polyunsaturated fatty acids and inflammatory bowel disease: A comprehensive review and future therapeutic perspectives. Int J Mol Sci. 2017;18.","DOI":"10.3390\/ijms18122619"},{"key":"2084_CR18","doi-asserted-by":"crossref","unstructured":"Inoue Y, Inui N, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, et al. Cumulative Incidence and Predictors of Progression in Corticosteroid-Naive Patients with Sarcoidosis. PLoS One. 2015;10.","DOI":"10.1371\/journal.pone.0143371"},{"key":"2084_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","volume":"149","author":"CW Hunninghake","year":"1994","unstructured":"Hunninghake CW, Gilbert S, Pueringer R, Dayton C, Floerchinger C, Helmers R, et al. Outcome of the Treatment for Sarcoidosis. Am J Resp Crit Care. 1994;149:893\u20138.","journal-title":"Am J Resp Crit Care"},{"key":"2084_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1378\/chest.129.6.1599","volume":"129","author":"JT Huggins","year":"2006","unstructured":"Huggins JT, Doelken P, Sahn SA, King L, Judson MA. Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest. 2006;129:1599\u2013604.","journal-title":"Chest"},{"key":"2084_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbamem.2015.10.009","volume":"1858","author":"TY Hou","year":"2016","unstructured":"Hou TY, Rola Barhoumid, Fan Y-Y, Rivera GM, Hannoush RN, McMurray DN, et al. n-3 polyunsaturated fatty acids suppress CD4 + T cell proliferation by altering phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2] organization. Biochim Et Biophys Acta-Biomembr. 2016;1858:85\u201396.","journal-title":"Biochim Et Biophys Acta-Biomembr."},{"key":"2084_CR22","doi-asserted-by":"publisher","first-page":"139-163-75","DOI":"10.1017\/S0007114517003385","volume":"119","author":"Y-Y Fan","year":"2018","unstructured":"Fan Y-Y, Natividad R. Fuentes, Hou TY, Barhoumi R, Li XC, Deutz NEP, et al. Remodelling of primary human CD4 + T cell plasma membrane order by n-3 PUFA. Br J Nutr. 2018;119:139-163-75.","journal-title":"Br J Nutr"},{"key":"2084_CR23","doi-asserted-by":"publisher","first-page":"353ra111","DOI":"10.1126\/scitranslmed.aaf7483","volume":"8","author":"V Chiurchi\u00f9","year":"2016","unstructured":"Chiurchi\u00f9 V, Alessandro Leuti, Dalli J, Jacobsson A, Battistini L, Maccarrone M, et al. Pro-resolving lipid mediators Resolvin D1, Resolvin D2 and Maresin 1 are critical in modulating T cell responses. Sci Transl Med. 2016;8:353ra111.","journal-title":"Sci Transl Med"},{"key":"2084_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3899\/jrheum.161068","volume":"44","author":"L Jeffery","year":"2017","unstructured":"Jeffery L, Fisk HL, Calder PC, Filer A, Raza K, Buckley CD, et al. Plasma levels of eicosapentaenoic acid are associated with anti-TNF responsiveness in rheumatoid arthritis and inhibit the etanercept-driven rise in Th17 cell differentiation in vitro. J Rheumatol. 2017;44:748\u201356.","journal-title":"J Rheumatol"},{"key":"2084_CR25","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3945\/jn.113.178178","volume":"143","author":"JM Monk","year":"2013","unstructured":"Monk JM, Hou TY, Turk HF, McMurray DN, Chapkin RS. n3 PUFAs reduce mouse CD4 + T-Cell ex vivo polarization into Th17 Cells. J Nutr. 2013;143:1501\u20138.","journal-title":"J Nutr"},{"key":"2084_CR26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3945\/jn.114.194407","volume":"144","author":"MJ Allen","year":"2014","unstructured":"Allen MJ, Fan YY, Monk JM, Hou TY, Barhoumi R, McMurray DN, et al. n-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4 + T cells. J Nutr. 2014;144:1306\u201313.","journal-title":"J Nutr"},{"key":"2084_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-04474-2","volume":"7","author":"T Onodera","year":"2017","unstructured":"Onodera T, Fukuhara A, Shin J, Hayakawa T, Otsuki M, Shimomura I. Eicosapentaenoic acid and 5-HEPE enhance macrophage-mediated Treg induction in mice. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"2084_CR28","first-page":"1","volume":"10","author":"M Lian","year":"2015","unstructured":"Lian M, Luo W, Sui Y, Li Z, Hua J. Dietary n-3 PUFA protects mice from Con a induced liver injury by modulating regulatory T cells and PPAR-\u03b3 expression. PLoS One. 2015;10:1\u201316.","journal-title":"PLoS One"},{"key":"2084_CR29","doi-asserted-by":"publisher","first-page":"7960","DOI":"10.1158\/0008-5472.CAN-10-1396","volume":"70","author":"HL Woodworth","year":"2010","unstructured":"Woodworth HL, McCaskey SJ, Duriancik DM, Clinthorne JF, Langohr IM, Gardner EM, et al. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res. 2010;70:7960\u20139.","journal-title":"Cancer Res"},{"key":"2084_CR30","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/jid.2014.488","volume":"135","author":"SC Han","year":"2015","unstructured":"Han SC, Koo DH, Kang NJ, Yoon WJ, Kang GJ, Kang HK, et al. Docosahexaenoic acid alleviates atopic dermatitis by generating tregs and IL-10\/TGF-\u03b2-modified macrophages via a TGF-\u03b2-dependent mechanism. J Invest Dermatol. 2015;135:1556\u201364. doi:https:\/\/doi.org\/10.1038\/jid.2014.488.","journal-title":"J Invest Dermatol"},{"key":"2084_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-017-0036-7","volume":"37","author":"T Aoki","year":"2017","unstructured":"Aoki T, Narumiya S. Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment. Inflamm Regen. 2017;37:1\u20135. doi:https:\/\/doi.org\/10.1186\/s41232-017-0036-7.","journal-title":"Inflamm Regen"},{"key":"2084_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI0214459","volume":"109","author":"K Kabashima","year":"2002","unstructured":"Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002;109:883\u201393.","journal-title":"J Clin Invest"},{"key":"2084_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ni.3868","volume":"18","author":"T Maj","year":"2018","unstructured":"Maj T, Wang W, Crespo J, Zhang H, Wang W, Zhao L, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol. 2018;18:1332\u201341.","journal-title":"Nat Immunol"},{"key":"2084_CR34","first-page":"4678","volume":"24","author":"Y Iizuka","year":"2010","unstructured":"Iizuka Y, Okuno T, Saeki K, Uozaki H, Okada S, Misaka T, et al. Protective role of the leukotriene B 4 receptor BLT2 in murine inflammatory colitis. FASEB J. 2010;24:4678\u201390.","journal-title":"FASEB J"},{"key":"2084_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejphar.2015.08.050","volume":"785","author":"RC Schwanke","year":"2016","unstructured":"Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins\u2019 actions in inflammatory bowel disease. Eur J Pharmacol. 2016;785:156\u201364. doi:https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.050.","journal-title":"Eur J Pharmacol."},{"key":"2084_CR36","doi-asserted-by":"crossref","unstructured":"Zhang RN, Pan Q, Zhang Z, Cao HX, Shen F, Fan JG. Saturated fatty acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic fatty liver disease by toll-like receptor 4-mediated innate immune response. Hepat Mon. 2015;15.","DOI":"10.5812\/hepatmon.15(5)2015.27909"},{"key":"2084_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/aem.58.2.624-629.1992","volume":"58","author":"L Wang","year":"1992","unstructured":"Wang L, Johnson EA. InhibitionofListeriamonocytogenes byFattyAcids and Monoglycerides. Appl Env Microbiol. 1992;58:624\u20139.","journal-title":"Appl Env Microbiol"},{"key":"2084_CR38","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1248\/bpb.27.1321","volume":"27","author":"T Kitahara","year":"2004","unstructured":"Kitahara T, Koyama N, Matsuda J, Aoyama Y, Hirakata Y, Kamihira S, et al. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull. 2004;27:1321\u20136.","journal-title":"Biol Pharm Bull"},{"key":"2084_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/JEP.S226632","volume":"11","author":"EJ Dingwoke","year":"2019","unstructured":"Dingwoke EJ, Adamude FA, Chukwuocha CE, Ambi AA, Nwobodo NN, Sallau AB, et al. Inhibition of trypanosoma evansi protein-tyrosine phosphatase by myristic acid analogues isolated from khaya senegalensis and tamarindus indica. J Exp Pharmacol. 2019;11:135\u201348.","journal-title":"J Exp Pharmacol"},{"key":"2084_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/AAC.05151-11","volume":"56","author":"CL Fischer","year":"2012","unstructured":"Fischer CL, Drake DR, Dawson D V., Blanchette DR, Brogden KA, Wertz PW. Antibacterial activity of sphingoid bases and fatty acids against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 2012;56:1157\u201361.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02084-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02084-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T18:02:48Z","timestamp":1659290568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02084-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02084-x","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki.\u3000The study protocol was approved by the Institutional Review Board of Hamamatsu University School of Medicine (No. 20\u2013228). Patient consent was waved because this was a retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interest in relation to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}